Publication | Closed Access

The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation

Trail-disc ActivationHepatocellular CarcinomaMedicinePharmacologyCell DeathAnti-cancer AgentTumor SuppressorOncologyCell BiologyTumor MicroenvironmentTrail-induced Apoptosis